- Home
- ZLAB vs AHR Comparison
ZLAB vs AHR Comparison
Compare ZLAB & AHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- AHR
- Stock Information
- Founded
- ZLAB 2013
- AHR 2013
- Country
- ZLAB China
- AHR United States
- Employees
- ZLAB N/A
- AHR N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- AHR
- Sector
- ZLAB Health Care
- AHR
- Exchange
- ZLAB Nasdaq
- AHR NYSE
- Market Cap
- ZLAB 3.6B
- AHR 5.2B
- IPO Year
- ZLAB 2017
- AHR 2024
- Fundamental
- Price
- ZLAB $36.40
- AHR $37.30
- Analyst Decision
- ZLAB Buy
- AHR Strong Buy
- Analyst Count
- ZLAB 5
- AHR 8
- Target Price
- ZLAB $54.28
- AHR $37.75
- AVG Volume (30 Days)
- ZLAB 886.5K
- AHR 2.0M
- Earning Date
- ZLAB 08-05-2025
- AHR 08-07-2025
- Dividend Yield
- ZLAB N/A
- AHR 2.70%
- EPS Growth
- ZLAB N/A
- AHR N/A
- EPS
- ZLAB N/A
- AHR N/A
- Revenue
- ZLAB $418,326,000.00
- AHR $2,104,227,000.00
- Revenue This Year
- ZLAB $44.07
- AHR $8.10
- Revenue Next Year
- ZLAB $49.13
- AHR $6.50
- P/E Ratio
- ZLAB N/A
- AHR N/A
- Revenue Growth
- ZLAB 43.72
- AHR 10.53
- 52 Week Low
- ZLAB $16.01
- AHR $14.79
- 52 Week High
- ZLAB $44.34
- AHR $37.25
- Technical
- Relative Strength Index (RSI)
- ZLAB 52.67
- AHR 66.23
- Support Level
- ZLAB $34.79
- AHR $35.70
- Resistance Level
- ZLAB $36.73
- AHR $36.85
- Average True Range (ATR)
- ZLAB 1.23
- AHR 0.96
- MACD
- ZLAB -0.46
- AHR -0.01
- Stochastic Oscillator
- ZLAB 25.91
- AHR 92.47
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About AHR AMERICAN HEALTHCARE REIT INC
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.